Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients.
Borghi C, Acelajado MC, Gupta Y, Jain S. Borghi C, et al. J Hum Hypertens. 2017 Oct;31(10):605-610. doi: 10.1038/jhh.2017.26. Epub 2017 Apr 6. J Hum Hypertens. 2017. PMID: 28382958 Review.
We will also assess the clinical evidence to evaluate the role of nebivolol in the management of elevated central systolic BP. Central BP indices offer better estimation of BP in central arteries and should be considered in routine clinic …
We will also assess the clinical evidence to evaluate the role of nebivolol in the management of elevated central
The role of Beta-blockers as first-line therapy in hypertension.
De Caterina AR, Leone AM. De Caterina AR, et al. Curr Atheroscler Rep. 2011 Apr;13(2):147-53. doi: 10.1007/s11883-010-0157-9. Curr Atheroscler Rep. 2011. PMID: 21207202 Review.
National and international guidelines still recommend β-blockers (BBs) as first-line agents in uncomplicated prevention of hypertension. However, it has been shown that BBs reduce blood pressure less than other drugs, specifically with regard to cen
National and international guidelines still recommend β-blockers (BBs) as first-line agents in uncomplicated prevention of hyperte
Feedback